291 related articles for article (PubMed ID: 25361209)
1. A focus on vaccination strategies.
Woodland DL
Viral Immunol; 2014 Nov; 27(9):421. PubMed ID: 25361209
[No Abstract] [Full Text] [Related]
2. Vaccination strategies.
Woodland DL
Viral Immunol; 2008 Mar; 21(1):1-2. PubMed ID: 18355117
[No Abstract] [Full Text] [Related]
3. A focus on humoral immunity to viral infections.
Woodland DL
Viral Immunol; 2012 Dec; 25(6):441. PubMed ID: 23216306
[No Abstract] [Full Text] [Related]
4. Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challenges.
Rappuoli R; Sutter G
Curr Opin Virol; 2017 Apr; 23():vi-viii. PubMed ID: 28622999
[No Abstract] [Full Text] [Related]
5. Viruses - from pathogens to vaccine carriers.
Small JC; Ertl HC
Curr Opin Virol; 2011 Oct; 1(4):241-5. PubMed ID: 22003377
[TBL] [Abstract][Full Text] [Related]
6. Editorial overview.
Ertl H; Pulendran B
Curr Opin Virol; 2011 Oct; 1(4):223-5. PubMed ID: 22440780
[No Abstract] [Full Text] [Related]
7. New viral vectors for infectious diseases and cancer.
Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
[TBL] [Abstract][Full Text] [Related]
8. Letter from the Editor.
Ellis R
Hum Vaccin Immunother; 2015; 11(10):2333. PubMed ID: 26376012
[No Abstract] [Full Text] [Related]
9. Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity.
Cervantes-Barragan L; Züst R; Maier R; Sierro S; Janda J; Levy F; Speiser D; Romero P; Rohrlich PS; Ludewig B; Thiel V
mBio; 2010 Sep; 1(4):. PubMed ID: 20844609
[TBL] [Abstract][Full Text] [Related]
10. VLPs and particle strategies for cancer vaccines.
Ungaro F; Conte C; Quaglia F; Tornesello ML; Buonaguro FM; Buonaguro L
Expert Rev Vaccines; 2013 Oct; 12(10):1173-93. PubMed ID: 24124878
[TBL] [Abstract][Full Text] [Related]
11. Developments in virus-like particle-based vaccines for infectious diseases and cancer.
Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
Expert Rev Vaccines; 2011 Nov; 10(11):1569-83. PubMed ID: 22043956
[TBL] [Abstract][Full Text] [Related]
12. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2013 Sep; 9(9):1825-6. PubMed ID: 24013451
[No Abstract] [Full Text] [Related]
13. DNA vaccines 2014 meeting: Highlights and overview.
Ugen KE; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1887-8. PubMed ID: 26158530
[No Abstract] [Full Text] [Related]
14. Antibodies, viruses and vaccines.
Burton DR
Nat Rev Immunol; 2002 Sep; 2(9):706-13. PubMed ID: 12209139
[TBL] [Abstract][Full Text] [Related]
15. Vaccines against dengue virus.
Woodland DL
Viral Immunol; 2015 Mar; 28(2):75. PubMed ID: 25689610
[No Abstract] [Full Text] [Related]
16. Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.
Capone S; D'Alise AM; Ammendola V; Colloca S; Cortese R; Nicosia A; Folgori A
Expert Rev Vaccines; 2013 Apr; 12(4):379-93. PubMed ID: 23560919
[TBL] [Abstract][Full Text] [Related]
17. [Immunity of viruses and the effectiveness of vaccines. Mode of virus infections and effectiveness of vaccines].
Shishido A
Nihon Rinsho; 1987 Oct; 45(10):2218-24. PubMed ID: 3448260
[No Abstract] [Full Text] [Related]
18. The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer.
Gómez CE; Nájera JL; Krupa M; Esteban M
Curr Gene Ther; 2008 Apr; 8(2):97-120. PubMed ID: 18393831
[TBL] [Abstract][Full Text] [Related]
19. Viruses as vaccine vectors for infectious diseases and cancer.
Draper SJ; Heeney JL
Nat Rev Microbiol; 2010 Jan; 8(1):62-73. PubMed ID: 19966816
[TBL] [Abstract][Full Text] [Related]
20. [Do dendritic cells modified with retroviral vectors carrying cytokine genes become a therapeutic tool?].
Szyda A; Rossowska J; Pajtasz-Piasecka E; Duś D
Postepy Hig Med Dosw (Online); 2006; 60():552-62. PubMed ID: 17115005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
